Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.33 |
| ▸ | CNR2 | P34972 | 5/20 | 0.33 |
| ▸ | CNR1 | P21554 | 2/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4313304 | 0.78 | TACR3 (0.41) | TACR3KDM4EKMT2AL3MBTL1ALOX5 | |
| SCHEMBL8882405 | 0.78 | SMN1; SMN2 (0.40) | TACR3KDM4EKMT2AL3MBTL1 | |
| SCHEMBL8883577 | 0.78 | TAS1R3 (0.36) | TACR3KDM4EKMT2AL3MBTL1ALOX5 | |
| SCHEMBL8883095 | 0.77 | TAS1R3 (0.35) | TACR3KMT2AALOX5CNR2CNR1 | |
| SCHEMBL8975448 | 0.75 | TAS1R3 (0.37) | TACR3KMT2AALOX5TAS1R3TAS1R1 | |
| SCHEMBL8975870 | 0.74 | TAS1R3 (0.38) | TACR3KMT2AALOX5TAS1R3TAS1R1 | |
| SCHEMBL8885183 | 0.74 | SMN1; SMN2 (0.43) | TACR3KDM4EKMT2AALOX5CNR2 | |
| SCHEMBL8882408 | 0.72 | SMN1; SMN2 (0.43) | TACR3KDM4EKMT2AL3MBTL1CNR2 | |
| SCHEMBL5013693 | 0.71 | KDM4E (0.41) | TACR3KDM4EKMT2AL3MBTL1CNR2 | |
| SCHEMBL1897757 | 0.70 | ALDH1A1 (0.40) | TACR3CNR2TAS1R3TAS1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858636-B2 | Use as coloring in coatings, printing inks and plastics, for producing aqueous polymer dispersions which absorb in the near infrared region, for producing markings which absorb infrared light and are invisible to the human eye, as infrared absorbers for heat management, active components in photovoltaics | BASF AKTIENGESELLSCHAFT (DE) | 2010-12-28 | — | — | US | disclosed |
| US-20080188660-A1 | Hexarylene and Pentarylene Tetracarboxylic Acid Diimides | BASF A.KTIENGESELLSCHAFT (DE) | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188660-A1 | Hexarylene and Pentarylene Tetracarboxylic Acid Diimides | CRYAA, UACA, CYP3A43 | TACR3 2844/4885KDM4E 3985/4885KMT2A 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.